Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den ...
Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...
Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...
Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...
German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...
Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...
"Am Tag, als Conny Kramer starb" kennen wohl auch heute noch die meisten von uns. Sängerin Juliane Werding wurde mit dem Lied deutschlandweit bekannt. Das macht sie heute. Juliane Werding war in ...
Zurück zur Übersicht HD Live Webcams Kiel, Holtenau, Schleuse Brunsbüttel, Schleuse Hamburg - St. Pauli - Landungsbrücken - Empire Riverside Hotel Röttenbach (bei Erlangen) - StorchenCam Lübeck - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback